We report our preliminary results concerning 25 patients with secretin
g pituitary adenomas treated with stereotactic radiosurgery after part
ial transsphenoidal surgery and followed over a 6-36 month-period. Amo
ng the 15 acromegalic patients, a decrease of 65% in mean GH levels wa
s achieved after 6 months and of 77% at 12 months after radiosurgery.
Presently, only 3 patients (20%) are considered as in remission (mean
GH and IGF1 level into the normal range). A decrease of 46% and 64% wa
s observed at 6 and 12 months after radiosurgery in 4 patients with pr
olactinomas although no normalization of PRL levels occurred. Presentl
y, 3/4 patients have individual PRL levels slightly above the normal r
ange. A normalization of Urinary Free Cortisol(UFC) was noticed in 4/6
(66%) patients with Gushing's disease within 6-12 months. No pituitar
y deficiency was noticed in this series with the exception of 4/25 pat
ients (16%) who received subtotal or total pituitary irradiation for p
ost-operative remnants of secreting adenomas poorly defined on MRI. On
e woman, who had undergone previously a conventional irradiation and p
resenting with a cavernous sinus adenoma reaching the optic nerve, dev
eloped an optic neuropathy. A second woman, with a cavernous sinus rem
nant, presented a cranial nerve palsy (VI) after the irradiation. We c
an conclude that radiosurgery using the Cobalt-60 Gamma-unit is, at le
ast, as effective as conventional radiotherapy in the control of pitui
tary hormone hypersecretion from postoperative adenomas remnants with
less adverse effects.